Literature DB >> 23714086

Diagnostic and prognostic value of low QRS voltages in cardiac AL amyloidosis.

Roberta Mussinelli1, Francesco Salinaro, Alessio Alogna, Michele Boldrini, Ambra Raimondi, Francesco Musca, Giovanni Palladini, Giampaolo Merlini, Stefano Perlini.   

Abstract

BACKGROUND: In cardiac AL amyloidosis, myocardial infiltration is typically associated with "low QRS voltages" at the 12-lead electrocardiogram (ECG). Although considered as one of the hallmarks of the disease, its reported prevalence varies from 45% to 70%, mainly because of nonhomogeneous definitions.
METHODS: To identify the "low QRS voltage" parameter having the best diagnostic value in identifying cardiac amyloidosis, and to assess its possible prognostic role, ECG and echocardiographic data were collected at diagnosis in 337 consecutive never-treated AL patients (233 with, 104 without cardiac involvement). Prognosis was assessed after a median follow-up of 14.5 months.
RESULTS: "Low QRS voltage" prevalence varied from 84.12% when using Sokolow-Lyon index ≤15 mm to 27.04% with the definition of low total voltages (QRS amplitude ≤5 mm in each peripheral and ≤10 mm in each precordial lead), the widely used definition of low peripheral voltages (≤5 mm in each peripheral lead) being able to identify 66.52% cardiac AL patients. The presence of "low peripheral voltages" was associated with a more severe cardiac involvement, and was able to differentiate Mayo stage II patients' survival (i.e., AL patients with intermediate prognosis). According to receiver operator characteristic (ROC) curve analysis, sensitivity and specificity were 58.72% and 80.00%, for a peripheral QRS amplitude ≤24.5 mm (the sum of QRS in all the 6 peripheral leads), and 76.26% and 65.00% for a Sokolow-Lyon index ≤11 mm.
CONCLUSIONS: In cardiac AL amyloidosis the prevalence of low QRS voltages is highly dependent on the method used for defining this ECG alteration. ©2013, Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2013        PMID: 23714086      PMCID: PMC6932192          DOI: 10.1111/anec.12036

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  36 in total

1.  Electrocardiographic findings in primary systemic amyloidosis and biopsy-proven cardiac involvement.

Authors:  Blaithnead Murtagh; Stephen C Hammill; Morie A Gertz; Robert A Kyle; A Jamil Tajik; Martha Grogan
Journal:  Am J Cardiol       Date:  2005-02-15       Impact factor: 2.778

2.  Prognostic value of fragmented QRS in cardiac AL amyloidosis.

Authors:  Stefano Perlini; Francesco Salinaro; Francesco Cappelli; Federico Perfetto; Franco Bergesio; Alessio Alogna; Roberta Mussinelli; Michele Boldrini; Ambra Raimondi; Francesco Musca; Giovanni Palladini; Giampaolo Merlini
Journal:  Int J Cardiol       Date:  2012-06-27       Impact factor: 4.164

3.  Clinically significant cardiac amyloidosis. Clinicopathologic findings in 15 patients.

Authors:  L M Buja; N B Khoi; W C Roberts
Journal:  Am J Cardiol       Date:  1970-10       Impact factor: 2.778

4.  Utility of combined indexes of electrocardiography and echocardiography in the diagnosis of biopsy proven primary cardiac amyloidosis.

Authors:  Zhongwei Cheng; Lin Kang; Zhuang Tian; Weiyun Chen; Wenjuan Guo; Jia Xu; Taibo Chen; Ligang Fang; Yong Zeng; Kang'an Cheng; Quan Fang
Journal:  Ann Noninvasive Electrocardiol       Date:  2011-01       Impact factor: 1.468

5.  Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis.

Authors:  Giovanni Palladini; Carlo Campana; Catherine Klersy; Alessandra Balduini; Giovanbattista Vadacca; Vittorio Perfetti; Stefano Perlini; Laura Obici; Edoardo Ascari; Gianvico Melzi d'Eril; Remigio Moratti; Giampaolo Merlini
Journal:  Circulation       Date:  2003-04-28       Impact factor: 29.690

Review 6.  Cardiac amyloidosis: a review and report of a new transthyretin (prealbumin) variant.

Authors:  A Hesse; K Altland; R P Linke; M R Almeida; M J Saraiva; A Steinmetz; B Maisch
Journal:  Br Heart J       Date:  1993-08

7.  Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective.

Authors:  Claudio Rapezzi; Candida Cristina Quarta; Laura Obici; Federico Perfetto; Simone Longhi; Fabrizio Salvi; Elena Biagini; Massimiliano Lorenzini; Francesco Grigioni; Ornella Leone; Francesco Cappelli; Giovanni Palladini; Paola Rimessi; Alessandra Ferlini; Giorgio Arpesella; Antonio Daniele Pinna; Giampaolo Merlini; Stefano Perlini
Journal:  Eur Heart J       Date:  2012-06-28       Impact factor: 29.983

8.  Noninvasive diagnosis of biopsy-proven cardiac amyloidosis.

Authors:  Joseph E Rahman; Emelie F Helou; Ramona Gelzer-Bell; Richard E Thompson; Chih Kuo; E Rene Rodriguez; Joshua M Hare; Kenneth L Baughman; Edward K Kasper
Journal:  J Am Coll Cardiol       Date:  2004-02-04       Impact factor: 24.094

9.  Cardiac arrhythmias in systemic amyloidosis: correlation with echocardiographic abnormalities.

Authors:  R H Falk; A Rubinow; A S Cohen
Journal:  J Am Coll Cardiol       Date:  1984-01       Impact factor: 24.094

10.  The electrocardiographic features associated with cardiac amyloidosis of variant transthyretin isoleucine 122 type in Afro-Caribbean patients.

Authors:  Jason Dungu; Prayman T Sattianayagam; Carol J Whelan; Simon D J Gibbs; Jennifer H Pinney; Sanjay M Banypersad; Dorota Rowczenio; Janet A Gilbertson; Helen J Lachmann; Ashutosh Wechalekar; Julian D Gillmore; Philip N Hawkins; Lisa J Anderson
Journal:  Am Heart J       Date:  2012-07       Impact factor: 4.749

View more
  23 in total

1.  Predictors of survival stratification in patients with wild-type cardiac amyloidosis.

Authors:  F Aus dem Siepen; R Bauer; A Voss; S Hein; M Aurich; J Riffel; D Mereles; C Röcken; S J Buss; H A Katus; Arnt V Kristen
Journal:  Clin Res Cardiol       Date:  2017-09-27       Impact factor: 5.460

Review 2.  New and Evolving Concepts Regarding the Prognosis and Treatment of Cardiac Amyloidosis.

Authors:  Stefano Perlini; Roberta Mussinelli; Francesco Salinaro
Journal:  Curr Heart Fail Rep       Date:  2016-12

Review 3.  Recent advances in the noninvasive strategies of cardiac amyloidosis.

Authors:  Lei Zhao; Quan Fang
Journal:  Heart Fail Rev       Date:  2016-11       Impact factor: 4.214

Review 4.  Addressing Common Questions Encountered in the Diagnosis and Management of Cardiac Amyloidosis.

Authors:  Mathew S Maurer; Perry Elliott; Raymond Comenzo; Marc Semigran; Claudio Rapezzi
Journal:  Circulation       Date:  2017-04-04       Impact factor: 29.690

5.  Cardiac Manifestations of Myotonic Dystrophy in a Pediatric Cohort.

Authors:  Laia Brunet Garcia; Ankita Hajra; Ella Field; Joseph Wacher; Helen Walsh; Gabrielle Norrish; Adnan Manzur; Francesco Muntoni; Pinki Munot; Stephanie Robb; Rosaline Quinlivan; Mariacristina Scoto; Giovanni Baranello; Anna Sarkozy; Luke Starling; Juan Pablo Kaski; Elena Cervi
Journal:  Front Pediatr       Date:  2022-06-09       Impact factor: 3.569

Review 6.  Utility and pitfalls of the electrocardiogram in the evaluation of cardiac amyloidosis.

Authors:  Perryn Lin Fei Ng; Yoke Ching Lim; Lauren Kay Mance Evangelista; Raymond Ching Chiew Wong; Ping Chai; Ching Hui Sia; Hoi Yin Loi; Tiong Cheng Yeo; Weiqin Lin
Journal:  Ann Noninvasive Electrocardiol       Date:  2022-05-14       Impact factor: 1.485

Review 7.  Role of imaging in the diagnosis and management of patients with cardiac amyloidosis: state of the art review and focus on emerging nuclear techniques.

Authors:  Wael A Aljaroudi; Milind Y Desai; W H Wilson Tang; Dermot Phelan; Manuel D Cerqueira; Wael A Jaber
Journal:  J Nucl Cardiol       Date:  2014-04       Impact factor: 5.952

Review 8.  Amyloid and the Heart.

Authors:  Aaron M Wolfson; Kevin S Shah; Jignesh K Patel
Journal:  Curr Cardiol Rep       Date:  2019-12-03       Impact factor: 2.931

Review 9.  Clinical approach to genetic testing in amyloid cardiomyopathy: from mechanism to effective therapies.

Authors:  Rabah Alreshq; Frederick L Ruberg
Journal:  Curr Opin Cardiol       Date:  2021-05-01       Impact factor: 2.161

Review 10.  Hypertrophic Cardiomyopathy and Primary Restrictive Cardiomyopathy: Similarities, Differences and Phenocopies.

Authors:  Riccardo Vio; Annalisa Angelini; Cristina Basso; Alberto Cipriani; Alessandro Zorzi; Paola Melacini; Gaetano Thiene; Alessandra Rampazzo; Domenico Corrado; Chiara Calore
Journal:  J Clin Med       Date:  2021-05-01       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.